Knowlex welcomes Xenex to showcase LightStrike

Medical Dealer | News | Xenex LightStrike robot

Healthcare associated infections (HAI) are a global problem and NHS Health Secretary Jeremy Hunt recently launched new plans to reduce infections in the NHS. Speakers representing NHS Improvement, NHS England and Public Health England will share their thoughts and plans during Knowlex’s Infection Prevention and Control (IPC) conference on February 22, 2017 in London. In preparation for the event, the Knowlex team carefully sought new technologies for infection prevention and selected Xenex LightStrike™ Germ-Zapping Robots™ to present at the exclusive invitation-only event on ultraviolet (UV) light room disinfection technology.

“Our mission is to seek, research and procure ideas, innovations and best practices to share with healthcare professionals. We are bringing together experts to discuss best practices for putting a stop to the infections caused by dangerous microorganisms residing in healthcare facilities and when we looked at the UV disinfection providers, Xenex clearly stood apart from many others. Multiple hospitals have experienced 50-100 percent decreases in their infection rates and published their results in peer-reviewed journals after using Xenex’s pulsed xenon UV technology to disinfect their facilities,” said Paul Anthony, Conference Producer for Knowlex.

LightStrike is ideal for use in hospitals worldwide because Xenex has patented protocols for use in multi-bed wards. The robot’s speed enables it to disinfect areas and rooms quickly so it can be used throughout the entire facility, including multi-bed wards, to enhance patient and healthcare worker safety.

Knowlex is an organization dedicated to disseminating information on research and innovative practices to help healthcare professionals in their working lives. Its objective is to help all organisations involved in health – acute trusts, CCGs, and local authorities – to become more efficient and effective in delivering better outcomes for the public.

Another important differentiator between room disinfection technologies is the fact that Xenex devices use pulsed xenon, a noble gas, to create UV-C light. Other UV providers use mercury bulbs to create single-spectrum continuous UV-C light. Mercury UV technology has not been proven to bring down infection rates in multiple facilities and because mercury is toxic, most hospitals are avoiding the use of mercury in their facilities.

Dr. Mark Stibich, co-founder and Chief Scientific Officer of Xenex, will present a workshop “No-Touch Disinfection: The New Frontier in Patient Safety” during the conference, where he will review current methods for no-touch disinfection for the hospital environment with a focus on evidence for clinical outcomes.

“Antibiotic resistance and HAIs are real threats today – in the UK and around the world. But when you remove the pathogens from the patient environment, infections and antibiotic use are reduced. We want hospital professionals to understand best practices for implementing UV disinfection in their facilities to stop the transmission of HAIs and enhance patient safety,” said Dr. Stibich.

For more information on the 2017 Infection Prevention and Control conference, visit http://www.infectioncontrol2017.co.uk/